Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Protalix BioTherapeutics (PLX) Receivables - Other (2019)

Protalix BioTherapeutics (PLX) has 6 years of Receivables - Other data on record, last reported at $26000.0 in Q4 2019.

  • For Q4 2019, Receivables - Other changed N/A year-over-year to $26000.0; the TTM value through Dec 2019 reached $26000.0, changed N/A, while the annual FY2019 figure was $26000.0, N/A changed from the prior year.
  • Receivables - Other reached $26000.0 in Q4 2019 per PLX's latest filing, down from $2.6 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $26000.0 in Q4 2019 and bottomed at $26000.0 in Q4 2019.